as 04-02-2025 4:00pm EST
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
Founded: | 1994 | Country: | United States |
Employees: | N/A | City: | NEW YORK |
Market Cap: | 2.0M | IPO Year: | 2016 |
Target Price: | N/A | AVG Volume (30 days): | 324.0K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.13 | EPS Growth: | N/A |
52 Week Low/High: | $0.18 - $1.87 | Next Earning Date: | 05-14-2025 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
PTIX Breaking Stock News: Dive into PTIX Ticker-Specific Updates for Smart Investing
ACCESSWIRE
5 months ago
ACCESSWIRE
5 months ago
Newsfile
10 months ago
GlobeNewswire
10 months ago
GlobeNewswire
10 months ago
CNW Group
10 months ago
GlobeNewswire
10 months ago
CNW Group
10 months ago
The information presented on this page, "PTIX Protagenic Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.